Hint mode is switched on Switch off
For swift navigation between sections

Korro Bio

PDF download

Choose all Reset all
Download Cancel
Organization name
Korro Bio Inc
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Korro Bio, Inc. operates as a biotechnology company. The Company discovers and develops medicines and small molecule drugs for the treatment of patients with skin disorders, muscle regeneration, and gastrointestinal diseases. Korro Bio serves health care sector in the United States.

Awards

News

09/03/2026 Korro Bio: Entry Into A Material Definitive Agreement, Results Of Operations And Financial Condition, Unregistered Shares Of Equity Securities, Regulation Fd Disclosure, Exhibits
07/11/2025 Korro Bio: Entry Into A Material Definitive Agreement, Results Of Operations And Financial Condition, Costs Associated With Exit Or Disposal Activities, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Financial Statements And Exhibits
07/10/2025 Korro Bio: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Financial Statements And Exhibits
11/06/2025 Korro Bio: Of Form 8k, Korro’s Board Of Directors’ Decision On The Stockholder Vote Regarding The Frequency Of Future Nonbinding Advisory Votes On The Compensation Of Korro’s Named Executive Officers
11/06/2025 Korro Bio: Submission Of Matters To A Vote Of Security Holders
All organization news

Documentation

IFRS/US GAAP reports

2025
I q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
III q eng
IV q eng
Show all Hide
Authorization required
You need to request access

Stocks

Public debt by currencies

Show more Hide

Codes

  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • CIK
    0001703647
  • EIN
    47-2324450
Registration is required to get access.